fda approved glp-1 receptor agonists of GLP-1RAs for the treatment of type 2 diabetes. US Food Nearly 20% of sites prescribed

By mitigating inflammation, L-Carnitine contributes to improving the overall comfort and appearance of sensitive skin

Because the recipes vary by pharmacy, the label matters more than the name

Treatment is usually recommended once every 3 months

Although GLP-1RAs can reduce body weight by 15%25% in controlled settings, real-world adherence is limited, and nearly 70% of patients experience weight regain after discontinuation, raising the risk of long-term pharmacological dependence ( Looking ahead, the future of GLP-1based therapy will depend on addressing safety concerns, improving long-term adherence, and expanding clinical indications

Recently a new peptide called retatrutide has been developed which, in our opinion, will be shown to have even more enhanced effects